BioNTech to Report Second Quarter 2025 Financial Results and Corporate Update on August 4, 2025
BioNTech (NASDAQ: BNTX) has scheduled its second quarter 2025 financial results announcement and corporate update for August 4, 2025. The company will host a conference call and webcast at 8:00 a.m. EDT (2:00 p.m. CEST) on the same day.
Investors and analysts can access the conference call via telephone by registering through a provided link, which will supply dial-in numbers and a PIN. The presentation slides and webcast will be accessible through the company's website, with a replay available for 30 days after the event.
BioNTech (NASDAQ: BNTX) ha programmato l'annuncio dei risultati finanziari del secondo trimestre 2025 e un aggiornamento aziendale per il 4 agosto 2025. La societ脿 terr脿 una conference call e una trasmissione in webcast alle 8:00 a.m. EDT (2:00 p.m. CEST) dello stesso giorno.
Investitori e analisti potranno partecipare alla conference call telefonicamente registrandosi tramite un link fornito, che fornir脿 numeri di accesso e un PIN. Le slide della presentazione e il webcast saranno disponibili sul sito web dell'azienda, con una replica accessibile per 30 giorni dopo l'evento.
BioNTech (NASDAQ: BNTX) ha programado el anuncio de sus resultados financieros del segundo trimestre de 2025 y una actualizaci贸n corporativa para el 4 de agosto de 2025. La compa帽铆a realizar谩 una llamada conferencia y una transmisi贸n en webcast a las 8:00 a.m. EDT (2:00 p.m. CEST) ese mismo d铆a.
Los inversores y analistas podr谩n acceder a la llamada conferencia por tel茅fono registr谩ndose a trav茅s de un enlace proporcionado, que facilitar谩 los n煤meros de acceso y un PIN. Las diapositivas de la presentaci贸n y el webcast estar谩n disponibles en el sitio web de la empresa, con una repetici贸n accesible durante 30 d铆as despu茅s del evento.
BioNTech (NASDAQ: BNTX)電� 2025雲� 2攵勱赴 鞛 鞁れ爜 氚滍憸 氚� 旮办梾 鞐呺嵃鞚错姼毳� 2025雲� 8鞗� 4鞚�搿� 鞓堨爼頄堨姷雼堧嫟. 須岇偓電� 臧欖潃 雮� 霃欕秬響滌鞁� 鞓れ爠 8鞁� (欷戩暀鞙犽熃鞐鞁滉皠 鞓ろ泟 2鞁�)鞐� 旎嵓霟办姢 旖滉臣 鞗轨簮鞀ろ姼毳� 歆勴枆頃� 鞓堨爼鞛呺媹雼�.
韴瀽鞛愳檧 鞎犽剱毽姢韸鸽姅 鞝滉车霅� 毵來伂毳� 韱淀暣 霌彪頃橂┐ 鞝勴檾搿� 旎嵓霟办姢 旖滌棎 彀胳棳頃� 靾� 鞛堨溂氅�, 鞝戩啀 氩堩樃鞕� PIN鞚� 鞝滉车霅╇媹雼�. 氚滍憸 鞛愲 鞀澕鞚措摐鞕� 鞗轨簮鞀ろ姼電� 須岇偓 鞗轨偓鞚错姼鞐愳劀 頇曥澑頃� 靾� 鞛堨溂氅�, 頄夓偓 頉� 30鞚缄皠 雼れ嫓氤搓赴 靹滊箘鞀る弰 鞝滉车霅╇媹雼�.
BioNTech (NASDAQ : BNTX) a pr茅vu l'annonce de ses r茅sultats financiers du deuxi猫me trimestre 2025 et une mise 脿 jour d'entreprise pour le 4 ao没t 2025. La soci茅t茅 organisera une conf茅rence t茅l茅phonique et une diffusion en webcast 脿 8h00 EDT (14h00 CEST) le m锚me jour.
Les investisseurs et analystes pourront acc茅der 脿 la conf茅rence t茅l茅phonique par t茅l茅phone en s'inscrivant via un lien fourni, qui donnera les num茅ros d'appel et un code PIN. Les diapositives de la pr茅sentation et le webcast seront disponibles sur le site internet de l'entreprise, avec une rediffusion accessible pendant 30 jours apr猫s l'茅v茅nement.
BioNTech (NASDAQ: BNTX) hat die Bekanntgabe der Finanzergebnisse f眉r das zweite Quartal 2025 sowie ein Unternehmensupdate f眉r den 4. August 2025 geplant. Das Unternehmen wird am selben Tag eine Telefonkonferenz und einen Webcast um 8:00 Uhr EDT (14:00 Uhr MESZ) abhalten.
Investoren und Analysten k枚nnen telefonisch an der Telefonkonferenz teilnehmen, indem sie sich 眉ber einen bereitgestellten Link registrieren, der Einwahlnummern und eine PIN bereitstellt. Die Pr盲sentationsfolien und der Webcast sind 眉ber die Website des Unternehmens zug盲nglich, mit einer Wiedergabe, die 30 Tage nach der Veranstaltung verf眉gbar ist.
- None.
- None.
MAINZ, Germany, July 21, 2025 (GLOBE NEWSWIRE) --听 (Nasdaq: BNTX, 鈥淏ioNTech鈥� or 鈥渢he Company鈥�) will announce its financial results for the second quarter 2025 on Monday, August 4, 2025. Additionally, the Company will host a conference call and webcast that day at 8:00 a.m. EDT (2:00 p.m. CEST) for investors, financial analysts and the general public to discuss its financial results and provide a corporate update.
To access the live conference call via telephone, please register via this . Once registered, dial-in numbers and a PIN will be provided. It is recommended to register at least one day in advance. The slide presentation and audio of the webcast will be available via this.听
Participants may also access the slides and the webcast of the conference call via the 鈥淓vents & Presentations鈥� page in the Investor Relations section of the Company鈥檚 website at聽. A replay of the webcast will be made available shortly after the call and archived on the Company鈥檚 website for 30 days following the call.
About BioNTech
Biopharmaceutical New Technologies (BioNTech) is a global next generation immunotherapy company pioneering novel investigative therapies for cancer and other serious diseases. BioNTech exploits a wide array of computational discovery and therapeutic modalities with the intent of rapid development of novel biopharmaceuticals. Its diversified portfolio of oncology product candidates aiming to address the full continuum of cancer includes mRNA cancer immunotherapies, next-generation immunomodulators and targeted therapies such as antibody-drug conjugates (ADCs) and innovative chimeric antigen receptor (CAR) T cell therapies. Based on its deep expertise in mRNA development and in-house manufacturing capabilities, BioNTech and its collaborators are researching and developing multiple mRNA vaccine candidates for a range of infectious diseases alongside its diverse oncology pipeline. BioNTech has established a broad set of relationships with multiple global and specialized pharmaceutical collaborators, including Bristol Myers Squibb, Duality Biologics, Fosun Pharma, Genentech, a member of the Roche Group, Genevant, Genmab, MediLink, OncoC4, Pfizer and Regeneron.
For more information, please visit聽.
CONTACTS
Investor Relations
Douglas Maffei, PhD
Media Relations
Jasmina Alatovic
FAQ
When will BioNTech (BNTX) report Q2 2025 earnings?
What time is BioNTech's Q2 2025 earnings call?
How can I access BioNTech's Q2 2025 earnings call?
How long will BioNTech's Q2 2025 earnings call replay be available?
